Gastrointestinal Tract Recovery in Patients Undergoing Bowel Resection: Results of a Randomized Trial of Alvimopan and Placebo With a Standardized Accelerated Postoperative Care Pathway | Gastrointestinal Surgery | JAMA Surgery | JAMA Network
[Skip to Navigation]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
Agency for Healthcare Research and Quality, Healthcare Costs and Utilization Project (HCUP): 2003 national statistics. Accessed May 15, 2006
Delaney  CP Clinical perspective on postoperative ileus and the effect of opiates.  Neurogastroenterol Motil 2004;16 ((suppl 2)) 61- 66PubMedGoogle ScholarCrossref
Livingston  EHPassaro  EP  Jr Postoperative ileus.  Dig Dis Sci 1990;35 (1) 121- 132PubMedGoogle ScholarCrossref
Delaney  CPLeslie  JBMarks  J  et al.  Postoperative ileus: profiles, risk factors, and definitions: a framework for optimizing surgical outcomes in patients undergoing major abdominal colorectal surgery. Bosker  G Clinical Consensus Update in General Surgery. Roswell, GA Pharmatecture LLC2006; Accessed May 15, 2006Google Scholar
Holte  KKehlet  H Postoperative ileus: a preventable event.  Br J Surg 2000;87 (11) 1480- 1493PubMedGoogle ScholarCrossref
Kehlet  HHolte  K Review of postoperative ileus.  Am J Surg 2001;182 (5A) ((suppl)) 3S- 10SPubMedGoogle ScholarCrossref
Leslie  JB Alvimopan for the management of postoperative ileus.  Ann Pharmacother 2005;39 (9) 1502- 1510PubMedGoogle ScholarCrossref
Sanger  GJHolzer  P Endogenous opioids and the gastrointestinal tract.  Semin Colon Rectal Surg 2005;16 (4) 197- 199Google ScholarCrossref
Austrup  MLKorean  G Analgesic agents for the postoperative period: opioids.  Surg Clin North Am 1999;79 (2) 253- 273PubMedGoogle ScholarCrossref
Holzer  P Opioids and opioid receptors in the enteric nervous system: from a problem in opioid analgesia to a possible new prokinetic therapy in humans.  Neurosci Lett 2004;361 (1-3) 192- 195PubMedGoogle ScholarCrossref
Kurz  ASessler  DI Opioid-induced bowel dysfunction: pathophysiology and potential new therapies.  Drugs 2003;63 (7) 649- 671PubMedGoogle ScholarCrossref
Behm  BStollman  N Postoperative ileus: etiologies and interventions.  Clin Gastroenterol Hepatol 2003;1 (2) 71- 80PubMedGoogle ScholarCrossref
Berend  KRLombardi  AV  JrMallory  THDodds  KLAdams  JB Ileus following total hip or knee arthroplasty is associated with increased risk of deep venous thrombosis and pulmonary embolism.  J Arthroplasty 2004;19 (7) ((suppl 2)) 82- 86PubMedGoogle ScholarCrossref
Pasqualotto  ACNedel  WLMachado  TSSevero  LC A comparative study of risk factors and outcome among outpatient-acquired and nosocomial candidaemia.  J Hosp Infect 2005;60 (2) 129- 134PubMedGoogle ScholarCrossref
Delaney  CPSenagore  AJViscusi  ER  et al.  Postoperative upper and lower gastrointestinal recovery and gastrointestinal morbidity in patients undergoing bowel resection: pooled analysis of placebo data from 3 randomized controlled trials.  Am J Surg 2006;191 (3) 315- 319PubMedGoogle ScholarCrossref
Delaney  CP Introduction, definitions, and clinical importance of postoperative ileus.  Semin Colon Rectal Surg 2005;16 (4) 182- 183Google ScholarCrossref
Bosio  RMDelaney  CPSenagore  AJ Economic impact of POI and prolonged length of stay.  Semin Colon Rectal Surg 2005;16 (4) 235- 238Google ScholarCrossref
Basse  LRaskov  HHHjort Jakobsen  D  et al.  Accelerated postoperative recovery programme after colonic resection improves physical performance, pulmonary function and body composition.  Br J Surg 2002;89 (4) 446- 453PubMedGoogle ScholarCrossref
Delaney  CPFazio  VWSenagore  AJRobinson  BHalverson  ALRemzi  FH “Fast track” postoperative management protocol for patients with high co-morbidity undergoing complex abdominal and pelvic colorectal surgery.  Br J Surg 2001;88 (11) 1533- 1538PubMedGoogle ScholarCrossref
Kehlet  HDahl  JB Anaesthesia, surgery, and challenges in postoperative recovery.  Lancet 2003;362 (9399) 1921- 1928PubMedGoogle ScholarCrossref
Moraca  RJSheldon  DGThirlby  RC The role of epidural anesthesia and analgesia in surgical practice.  Ann Surg 2003;238 (5) 663- 673PubMedGoogle ScholarCrossref
Basse  LThorbol  JELossl  KKehlet  H Colonic surgery with accelerated rehabilitation or conventional care [published corrections appear in Dis Colon Rectum. 2004;47(6):951 and Dis Colon Rectum. 2005;48(8):1673].  Dis Colon Rectum 2004;47 (3) 271- 278PubMedGoogle ScholarCrossref
Hjort Jakobsen  DSonne  EBasse  LBisgaard  TKehlet  H Convalescence after colonic resection with fast-track vs conventional care.  Scand J Surg 2004;93 (1) 24- 28PubMedGoogle Scholar
Basse  LHjort Jakobsen  DBillesbolle  PWerner  MKehlet  H A clinical pathway to accelerate recovery after colonic resection.  Ann Surg 2000;232 (1) 51- 57PubMedGoogle ScholarCrossref
DiFronzo  LAYamin  NPatel  KO'Connell  TX Benefits of early feeding and early hospital discharge in elderly patients undergoing open colon resection.  J Am Coll Surg 2003;197 (5) 747- 752PubMedGoogle ScholarCrossref
Nelson  RTse  BEdwards  S Systematic review of prophylactic nasogastric decompression after abdominal operations.  Br J Surg 2005;92 (6) 673- 680PubMedGoogle ScholarCrossref
Stewart  BTWoods  RJCollopy  BTFink  RJMackay  JRKeck  JO Early feeding after elective open colorectal resections: a prospective randomized trial.  Aust N Z J Surg 1998;68 (2) 125- 128PubMedGoogle ScholarCrossref
Delaney  CPWeese  JLHyman  NH  et al. Alvimopan Postoperative Ileus Study Group, Phase III trial of alvimopan, a novel, peripherally acting, mu opioid antagonist, for postoperative ileus after major abdominal surgery.  Dis Colon Rectum 2005;48 (6) 1114- 1129PubMedGoogle ScholarCrossref
Viscusi  ERGoldstein  SWitkowski  T  et al.  Alvimopan, a peripherally acting mu-opioid receptor antagonist, compared with placebo in postoperative ileus after major abdominal surgery: results of a randomized, double-blind, controlled study.  Surg Endosc 2006;20 (1) 64- 70PubMedGoogle ScholarCrossref
Wolff  BGMichelassi  FGerkin  TM  et al.  Alvimopan, a novel, peripherally acting mu opioid antagonist: results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial of major abdominal surgery and postoperative ileus.  Ann Surg 2004;240 (4) 728- 735PubMedGoogle Scholar
Kariv  YViscusi  EWolff  B  et al.  Efficacy of alvimopan, a peripherally acting mu-opioid receptor (PAM-OR) antagonist, and timing of preoperative dosing: pharmacodynamic and pharmacokinetic consideration in patients undergoing open laparotomy [abstract 1326].  Pharmacotherapy 2005;25 (10) 1505Google Scholar
Bungard  TJKale-Pradhan  PB Prokinetic agents for the treatment of postoperative ileus in adults: a review of the literature.  Pharmacotherapy 1999;19 (4) 416- 423PubMedGoogle ScholarCrossref
Delaney  CPWolff  BGViscusi  ER  et al.  Alvimopan, for postoperative ileus following bowel resection: a pooled analysis of phase III studies.  Ann Surg 2007;245 (3) 355- 363PubMedGoogle ScholarCrossref
Myrianthefs  PMKalafati  MSamara  IBaltopoulos  GJ Nosocomial pneumonia.  Crit Care Nurs Q 2004;27 (3) 241- 257PubMedGoogle ScholarCrossref
Olaechea  PMUlibarrena  MAAlvarez-Lerma  FInsausti  JPalomar  MDe la Cal  MAENVIN-UCI Study Group, Factors related to hospital stay among patients with nosocomial infection acquired in the intensive care unit.  Infect Control Hosp Epidemiol 2003;24 (3) 207- 213PubMedGoogle ScholarCrossref
Safdar  NMaki  DG The commonality of risk factors for nosocomial colonization and infection with antimicrobial-resistant Staphylococcus aureus, enterococcus, gram-negative bacilli, Clostridium difficile, and Candida Ann Intern Med 2002;136 (11) 834- 844PubMedGoogle ScholarCrossref
Wolff  BGDelaney  CPViscusi  ER  et al.  Alvimopan is associated with reduced hospital length of stay, lowered readmission rates, and decreased costs after bowel resection.  Presented at: American Society of Health-System Pharmacists Summer Meeting and Exhibition June 27, 2006 Orlando, FL
Nascimbeni  RCadoni  RDi Fabio  FCasella  CSalerni  B Hospitalization after open colectomy: expectations and practice in general surgery.  Surg Today 2005;35 (5) 371- 376PubMedGoogle ScholarCrossref
Udelnow  ALeinung  SSchreiter  DSchonfelder  MWurl  P Impact of age on in-hospital mortality of surgical patients in a German university hospital.  Arch Gerontol Geriatr 2005;41 (3) 281- 288PubMedGoogle ScholarCrossref
Original Article
November 17, 2008

Gastrointestinal Tract Recovery in Patients Undergoing Bowel Resection: Results of a Randomized Trial of Alvimopan and Placebo With a Standardized Accelerated Postoperative Care Pathway

Author Affiliations

Author Affiliations: Section of Colorectal and Gastrointestinal Surgery, Duke University Medical Center, Durham, North Carolina (Dr Ludwig); Division of Colorectal Surgery, Beth Israel Medical Center, New York, New York (Dr Enker); Division of Colorectal Surgery, University Hospitals of Cleveland, Cleveland, Ohio (Dr Delaney); Division of Colon and Rectal Surgery, Mayo Clinic, Rochester, Minnesota (Dr Wolff); and Adolor Corp, Exton, Pennsylvania (Drs Du, Fort, and Techner, Ms Cherubini, and Mr Cucinotta). Dr Ludwig is now with the Department of Surgery, Medical College of Wisconsin, Milwaukee.

Arch Surg. 2008;143(11):1098-1105. doi:10.1001/archsurg.143.11.1098

Objective  To investigate the efficacy and safety of alvimopan, 12 mg, administered orally 30 to 90 minutes preoperatively and twice daily postoperatively in conjunction with a standardized accelerated postoperative care pathway for managing postoperative ileus after bowel resection.

Design, Setting, and Patients  This multicenter, randomized, placebo-controlled, double-blind, phase 3 trial enrolled adult patients undergoing partial bowel resection with primary anastomosis by laparotomy and scheduled to receive intravenous, opioid-based, patient-controlled analgesia. A standardized accelerated postoperative care pathway including early ambulation, oral feeding, and postoperative nasogastric tube removal was used to facilitate gastrointestinal (GI) tract recovery in all of the patients.

Main Outcome Measures  The primary end point was time to GI-2 recovery (toleration of solid food and first bowel movement). Secondary end points included time to GI-3 recovery (toleration of solid food and first flatus or bowel movement), hospital discharge order written, and actual hospital discharge. Postoperative length of hospital stay based on calendar day of hospital discharge order written, opioid consumption, and overall postoperative ileus–related morbidity were recorded.

Results  Alvimopan, 12 mg, was well tolerated and significantly accelerated GI-2 recovery, GI-3 recovery, and actual hospital discharge compared with a standardized accelerated postoperative care pathway alone (hazard ratio = 1.5, 1.5, and 1.4, respectively; P < .001 for all). Time to hospital discharge order written as measured by hazard ratio (1.4) and by postoperative calendar days (mean for alvimopan, 5.2 days; mean for placebo, 6.2 days) was also accelerated. Opioid consumption was comparable between groups, and alvimopan was associated with reduced postoperative ileus–related morbidity compared with placebo.

Conclusions  Alvimopan, 12 mg, administered 30 to 90 minutes before and twice daily after bowel resection is well tolerated, accelerates GI tract recovery, and reduces postoperative ileus–related morbidity without compromising opioid analgesia.

Trial Registration Identifier: NCT00205842